ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Cancer Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-1P7758
Home | Market Reports | Health| Men s Health
Global Prostate Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Prostate Cancer Drugs Market Research Report 2025

Code: QYRE-Auto-1P7758
Report
August 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Prostate Cancer Drugs Market Size

The global market for Prostate Cancer Drugs was valued at US$ 7325 million in the year 2024 and is projected to reach a revised size of US$ 11310 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Prostate Cancer Drugs Market

Prostate Cancer Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Drugs.
The Prostate Cancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prostate Cancer Drugs Market Report

Report Metric Details
Report Name Prostate Cancer Drugs Market
Accounted market size in year US$ 7325 million
Forecasted market size in 2031 US$ 11310 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
Segment by Application
  • Clinics
  • Hospitals
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis, Amgen, Bayer HealthCare, Ferring Pharmaceutical, Janssen Pharmaceuticals, Endo Pharmaceuticals, BMS, Takeda Pharmaceuticals, Northwest Biotherapeutics, Teva Pharmaceutical, Boehringer Ingelheim, Foresee Pharmaceuticals, Tokai Pharmaceuticals, Spectrum Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prostate Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Prostate Cancer Drugs Market growing?

Ans: The Prostate Cancer Drugs Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Prostate Cancer Drugs Market size in 2031?

Ans: The Prostate Cancer Drugs Market size in 2031 will be US$ 11310 million.

Who are the main players in the Prostate Cancer Drugs Market report?

Ans: The main players in the Prostate Cancer Drugs Market are AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis, Amgen, Bayer HealthCare, Ferring Pharmaceutical, Janssen Pharmaceuticals, Endo Pharmaceuticals, BMS, Takeda Pharmaceuticals, Northwest Biotherapeutics, Teva Pharmaceutical, Boehringer Ingelheim, Foresee Pharmaceuticals, Tokai Pharmaceuticals, Spectrum Pharmaceuticals

What are the Application segmentation covered in the Prostate Cancer Drugs Market report?

Ans: The Applications covered in the Prostate Cancer Drugs Market report are Clinics, Hospitals, Others

What are the Type segmentation covered in the Prostate Cancer Drugs Market report?

Ans: The Types covered in the Prostate Cancer Drugs Market report are Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

1 Prostate Cancer Drugs Market Overview
1.1 Product Definition
1.2 Prostate Cancer Drugs by Type
1.2.1 Global Prostate Cancer Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hormonal Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Prostate Cancer Drugs by Application
1.3.1 Global Prostate Cancer Drugs Market Value by Application (2024 VS 2031)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Prostate Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Drugs Revenue 2020-2031
1.4.2 Global Prostate Cancer Drugs Sales 2020-2031
1.4.3 Global Prostate Cancer Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prostate Cancer Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prostate Cancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostate Cancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Cancer Drugs, Product Type & Application
2.7 Global Key Manufacturers of Prostate Cancer Drugs, Date of Enter into This Industry
2.8 Global Prostate Cancer Drugs Market Competitive Situation and Trends
2.8.1 Global Prostate Cancer Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prostate Cancer Drugs Players Market Share by Revenue
2.8.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostate Cancer Drugs Market Scenario by Region
3.1 Global Prostate Cancer Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prostate Cancer Drugs Sales by Region: 2020-2031
3.2.1 Global Prostate Cancer Drugs Sales by Region: 2020-2025
3.2.2 Global Prostate Cancer Drugs Sales by Region: 2026-2031
3.3 Global Prostate Cancer Drugs Revenue by Region: 2020-2031
3.3.1 Global Prostate Cancer Drugs Revenue by Region: 2020-2025
3.3.2 Global Prostate Cancer Drugs Revenue by Region: 2026-2031
3.4 North America Prostate Cancer Drugs Market Facts & Figures by Country
3.4.1 North America Prostate Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prostate Cancer Drugs Sales by Country (2020-2031)
3.4.3 North America Prostate Cancer Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Cancer Drugs Market Facts & Figures by Country
3.5.1 Europe Prostate Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prostate Cancer Drugs Sales by Country (2020-2031)
3.5.3 Europe Prostate Cancer Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Cancer Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Prostate Cancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prostate Cancer Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Prostate Cancer Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Cancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Prostate Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prostate Cancer Drugs Sales by Country (2020-2031)
3.7.3 Latin America Prostate Cancer Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prostate Cancer Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prostate Cancer Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Cancer Drugs Sales by Type (2020-2031)
4.1.1 Global Prostate Cancer Drugs Sales by Type (2020-2025)
4.1.2 Global Prostate Cancer Drugs Sales by Type (2026-2031)
4.1.3 Global Prostate Cancer Drugs Sales Market Share by Type (2020-2031)
4.2 Global Prostate Cancer Drugs Revenue by Type (2020-2031)
4.2.1 Global Prostate Cancer Drugs Revenue by Type (2020-2025)
4.2.2 Global Prostate Cancer Drugs Revenue by Type (2026-2031)
4.2.3 Global Prostate Cancer Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Prostate Cancer Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prostate Cancer Drugs Sales by Application (2020-2031)
5.1.1 Global Prostate Cancer Drugs Sales by Application (2020-2025)
5.1.2 Global Prostate Cancer Drugs Sales by Application (2026-2031)
5.1.3 Global Prostate Cancer Drugs Sales Market Share by Application (2020-2031)
5.2 Global Prostate Cancer Drugs Revenue by Application (2020-2031)
5.2.1 Global Prostate Cancer Drugs Revenue by Application (2020-2025)
5.2.2 Global Prostate Cancer Drugs Revenue by Application (2026-2031)
5.2.3 Global Prostate Cancer Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Prostate Cancer Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Prostate Cancer Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Company Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Astra Zeneca
6.3.1 Astra Zeneca Company Information
6.3.2 Astra Zeneca Description and Business Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio
6.3.5 Astra Zeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Prostate Cancer Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck Group
6.7.1 Merck Group Company Information
6.7.2 Merck Group Description and Business Overview
6.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Group Prostate Cancer Drugs Product Portfolio
6.7.5 Merck Group Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Prostate Cancer Drugs Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Amgen
6.9.1 Amgen Company Information
6.9.2 Amgen Description and Business Overview
6.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amgen Prostate Cancer Drugs Product Portfolio
6.9.5 Amgen Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Company Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Company Information
6.11.2 Ferring Pharmaceutical Description and Business Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.11.5 Ferring Pharmaceutical Recent Developments/Updates
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Company Information
6.12.2 Janssen Pharmaceuticals Description and Business Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.12.5 Janssen Pharmaceuticals Recent Developments/Updates
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Company Information
6.13.2 Endo Pharmaceuticals Description and Business Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.13.5 Endo Pharmaceuticals Recent Developments/Updates
6.14 BMS
6.14.1 BMS Company Information
6.14.2 BMS Description and Business Overview
6.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BMS Prostate Cancer Drugs Product Portfolio
6.14.5 BMS Recent Developments/Updates
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Company Information
6.15.2 Takeda Pharmaceuticals Description and Business Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.15.5 Takeda Pharmaceuticals Recent Developments/Updates
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Company Information
6.16.2 Northwest Biotherapeutics Description and Business Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio
6.16.5 Northwest Biotherapeutics Recent Developments/Updates
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Company Information
6.17.2 Teva Pharmaceutical Description and Business Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio
6.17.5 Teva Pharmaceutical Recent Developments/Updates
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Company Information
6.18.2 Boehringer Ingelheim Description and Business Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio
6.18.5 Boehringer Ingelheim Recent Developments/Updates
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Company Information
6.19.2 Foresee Pharmaceuticals Description and Business Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.19.5 Foresee Pharmaceuticals Recent Developments/Updates
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Company Information
6.20.2 Tokai Pharmaceuticals Description and Business Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.20.5 Tokai Pharmaceuticals Recent Developments/Updates
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Company Information
6.21.2 Spectrum Pharmaceuticals Description and Business Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio
6.21.5 Spectrum Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Cancer Drugs Industry Chain Analysis
7.2 Prostate Cancer Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Cancer Drugs Production Mode & Process Analysis
7.4 Prostate Cancer Drugs Sales and Marketing
7.4.1 Prostate Cancer Drugs Sales Channels
7.4.2 Prostate Cancer Drugs Distributors
7.5 Prostate Cancer Drugs Customer Analysis
8 Prostate Cancer Drugs Market Dynamics
8.1 Prostate Cancer Drugs Industry Trends
8.2 Prostate Cancer Drugs Market Drivers
8.3 Prostate Cancer Drugs Market Challenges
8.4 Prostate Cancer Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
List of Tables
 Table 1. Global Prostate Cancer Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prostate Cancer Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prostate Cancer Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prostate Cancer Drugs Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Prostate Cancer Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prostate Cancer Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prostate Cancer Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prostate Cancer Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prostate Cancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prostate Cancer Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prostate Cancer Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Prostate Cancer Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prostate Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prostate Cancer Drugs Sales by Region (2020-2025) & (K MT)
 Table 18. Global Prostate Cancer Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Prostate Cancer Drugs Sales by Region (2026-2031) & (K MT)
 Table 20. Global Prostate Cancer Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Prostate Cancer Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prostate Cancer Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Prostate Cancer Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prostate Cancer Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Prostate Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prostate Cancer Drugs Sales by Country (2020-2025) & (K MT)
 Table 27. North America Prostate Cancer Drugs Sales by Country (2026-2031) & (K MT)
 Table 28. North America Prostate Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prostate Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prostate Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prostate Cancer Drugs Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Prostate Cancer Drugs Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Prostate Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prostate Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prostate Cancer Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prostate Cancer Drugs Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Prostate Cancer Drugs Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Prostate Cancer Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prostate Cancer Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prostate Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prostate Cancer Drugs Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Prostate Cancer Drugs Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Prostate Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prostate Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prostate Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prostate Cancer Drugs Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Prostate Cancer Drugs Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prostate Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prostate Cancer Drugs Sales (K MT) by Type (2020-2025)
 Table 51. Global Prostate Cancer Drugs Sales (K MT) by Type (2026-2031)
 Table 52. Global Prostate Cancer Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Prostate Cancer Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Prostate Cancer Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prostate Cancer Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prostate Cancer Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Prostate Cancer Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Prostate Cancer Drugs Price (USD/MT) by Type (2020-2025)
 Table 59. Global Prostate Cancer Drugs Price (USD/MT) by Type (2026-2031)
 Table 60. Global Prostate Cancer Drugs Sales (K MT) by Application (2020-2025)
 Table 61. Global Prostate Cancer Drugs Sales (K MT) by Application (2026-2031)
 Table 62. Global Prostate Cancer Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Prostate Cancer Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Prostate Cancer Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prostate Cancer Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prostate Cancer Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Prostate Cancer Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Prostate Cancer Drugs Price (USD/MT) by Application (2020-2025)
 Table 69. Global Prostate Cancer Drugs Price (USD/MT) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. AbbVie Prostate Cancer Drugs Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Astellas Pharma Company Information
 Table 76. Astellas Pharma Description and Business Overview
 Table 77. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Astellas Pharma Prostate Cancer Drugs Product
 Table 79. Astellas Pharma Recent Developments/Updates
 Table 80. Astra Zeneca Company Information
 Table 81. Astra Zeneca Description and Business Overview
 Table 82. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Astra Zeneca Prostate Cancer Drugs Product
 Table 84. Astra Zeneca Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Prostate Cancer Drugs Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Sanofi Prostate Cancer Drugs Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. GlaxoSmithKline Company Information
 Table 96. GlaxoSmithKline Description and Business Overview
 Table 97. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. GlaxoSmithKline Prostate Cancer Drugs Product
 Table 99. GlaxoSmithKline Recent Developments/Updates
 Table 100. Merck Group Company Information
 Table 101. Merck Group Description and Business Overview
 Table 102. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Merck Group Prostate Cancer Drugs Product
 Table 104. Merck Group Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Novartis Prostate Cancer Drugs Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Amgen Company Information
 Table 111. Amgen Description and Business Overview
 Table 112. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Amgen Prostate Cancer Drugs Product
 Table 114. Amgen Recent Developments/Updates
 Table 115. Bayer HealthCare Company Information
 Table 116. Bayer HealthCare Description and Business Overview
 Table 117. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Bayer HealthCare Prostate Cancer Drugs Product
 Table 119. Bayer HealthCare Recent Developments/Updates
 Table 120. Ferring Pharmaceutical Company Information
 Table 121. Ferring Pharmaceutical Description and Business Overview
 Table 122. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Ferring Pharmaceutical Prostate Cancer Drugs Product
 Table 124. Ferring Pharmaceutical Recent Developments/Updates
 Table 125. Janssen Pharmaceuticals Company Information
 Table 126. Janssen Pharmaceuticals Description and Business Overview
 Table 127. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Janssen Pharmaceuticals Prostate Cancer Drugs Product
 Table 129. Janssen Pharmaceuticals Recent Developments/Updates
 Table 130. Endo Pharmaceuticals Company Information
 Table 131. Endo Pharmaceuticals Description and Business Overview
 Table 132. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. Endo Pharmaceuticals Prostate Cancer Drugs Product
 Table 134. Endo Pharmaceuticals Recent Developments/Updates
 Table 135. BMS Company Information
 Table 136. BMS Description and Business Overview
 Table 137. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 138. BMS Prostate Cancer Drugs Product
 Table 139. BMS Recent Developments/Updates
 Table 140. Takeda Pharmaceuticals Company Information
 Table 141. Takeda Pharmaceuticals Description and Business Overview
 Table 142. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 143. Takeda Pharmaceuticals Prostate Cancer Drugs Product
 Table 144. Takeda Pharmaceuticals Recent Developments/Updates
 Table 145. Northwest Biotherapeutics Company Information
 Table 146. Northwest Biotherapeutics Description and Business Overview
 Table 147. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 148. Northwest Biotherapeutics Prostate Cancer Drugs Product
 Table 149. Northwest Biotherapeutics Recent Developments/Updates
 Table 150. Teva Pharmaceutical Company Information
 Table 151. Teva Pharmaceutical Description and Business Overview
 Table 152. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 153. Teva Pharmaceutical Prostate Cancer Drugs Product
 Table 154. Teva Pharmaceutical Recent Developments/Updates
 Table 155. Boehringer Ingelheim Company Information
 Table 156. Boehringer Ingelheim Description and Business Overview
 Table 157. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 158. Boehringer Ingelheim Prostate Cancer Drugs Product
 Table 159. Boehringer Ingelheim Recent Developments/Updates
 Table 160. Foresee Pharmaceuticals Company Information
 Table 161. Foresee Pharmaceuticals Description and Business Overview
 Table 162. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 163. Foresee Pharmaceuticals Prostate Cancer Drugs Product
 Table 164. Foresee Pharmaceuticals Recent Developments/Updates
 Table 165. Tokai Pharmaceuticals Company Information
 Table 166. Tokai Pharmaceuticals Description and Business Overview
 Table 167. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 168. Tokai Pharmaceuticals Prostate Cancer Drugs Product
 Table 169. Tokai Pharmaceuticals Recent Developments/Updates
 Table 170. Spectrum Pharmaceuticals Company Information
 Table 171. Spectrum Pharmaceuticals Description and Business Overview
 Table 172. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 173. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
 Table 174. Spectrum Pharmaceuticals Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Prostate Cancer Drugs Distributors List
 Table 178. Prostate Cancer Drugs Customers List
 Table 179. Prostate Cancer Drugs Market Trends
 Table 180. Prostate Cancer Drugs Market Drivers
 Table 181. Prostate Cancer Drugs Market Challenges
 Table 182. Prostate Cancer Drugs Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prostate Cancer Drugs
 Figure 2. Global Prostate Cancer Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prostate Cancer Drugs Market Share by Type: 2024 & 2031
 Figure 4. Hormonal Therapy Product Picture
 Figure 5. Chemotherapy Product Picture
 Figure 6. Immunotherapy Product Picture
 Figure 7. Targeted Therapy Product Picture
 Figure 8. Global Prostate Cancer Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prostate Cancer Drugs Market Share by Application: 2024 & 2031
 Figure 10. Clinics
 Figure 11. Hospitals
 Figure 12. Others
 Figure 13. Global Prostate Cancer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Prostate Cancer Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Prostate Cancer Drugs Sales (2020-2031) & (K MT)
 Figure 16. Global Prostate Cancer Drugs Average Price (USD/MT) & (2020-2031)
 Figure 17. Prostate Cancer Drugs Report Years Considered
 Figure 18. Prostate Cancer Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Prostate Cancer Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Prostate Cancer Drugs Players: Market Share by Revenue in Prostate Cancer Drugs in 2024
 Figure 21. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Prostate Cancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Prostate Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Prostate Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Prostate Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Prostate Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Prostate Cancer Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Prostate Cancer Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Prostate Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Prostate Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Prostate Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Prostate Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Prostate Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Prostate Cancer Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Prostate Cancer Drugs by Type (2020-2031)
 Figure 57. Global Prostate Cancer Drugs Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Prostate Cancer Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Prostate Cancer Drugs by Application (2020-2031)
 Figure 60. Global Prostate Cancer Drugs Price (USD/MT) by Application (2020-2031)
 Figure 61. Prostate Cancer Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions